MEMORY PHARMACEUTICALS

33 Chestnut St, Tenafly, New Jersey, United States

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

100.0%

Trial Status Distribution

Completed

60.0%

Unknown

40.0%

Clinical Trials

Trials sponsored by this organization (5)

A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients

Phase 2

Unknown

interventional

Aug 200812 participants

Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia

Phase 2

Unknown

interventional

Dec 2007160 participants

Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Phase 2

Completed

interventional

Feb 200780 participants

Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

Phase 2

Completed

interventional

Sep 200660 participants

Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Phase 2

Completed

interventional

Nov 2005183 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations